Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Other Accumulated Expenses (2019 - 2023)

Alx Oncology Holdings' Other Accumulated Expenses history spans 5 years, with the latest figure at $265000.0 for Q3 2023.

  • For Q3 2023, Other Accumulated Expenses changed N/A year-over-year to $265000.0; the TTM value through Sep 2023 reached $265000.0, changed N/A, while the annual FY2022 figure was $2.0 million, 697.67% up from the prior year.
  • Other Accumulated Expenses for Q3 2023 was $265000.0 at Alx Oncology Holdings, up from $258000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.0 million in Q4 2022 and bottomed at $102000.0 in Q3 2021.
  • The 5-year median for Other Accumulated Expenses is $222500.0 (2020), against an average of $376700.0.
  • The largest annual shift saw Other Accumulated Expenses crashed 57.5% in 2021 before it surged 697.67% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $136000.0 in 2019, then grew by 11.03% to $151000.0 in 2020, then surged by 70.2% to $257000.0 in 2021, then soared by 697.67% to $2.0 million in 2022, then crashed by 87.07% to $265000.0 in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Other Accumulated Expenses are $265000.0 (Q3 2023), $258000.0 (Q1 2023), and $2.0 million (Q4 2022).